Jefferies, Leerink, Goldman Sachs, Morgan Stanley, Guggenheim and BMO Capital acted as joint book running managers for the offering.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GPCR:
- Structure Therapeutics Stock (GPCR) Spikes 102% as Obesity Trial Beats Eli Lilly, Novo Nordisk
- Why is Biotech Stock iBio Up over 50%?
- Promising Outlook for Structure Therapeutics’ Aleniglipron: Buy Rating Affirmed Amid Strong Phase 2b Results and Market Potential
- Structure Therapeutics price target raised to $100 from $60 at Citi
- Structure Therapeutics price target raised to $99 from $61 at Clear Street